(Q36930081)

17 August 2017

1 reference

title

Attempts to optimize active specific immunotherapy for melanoma (English)

1 reference

17 August 2017

Attempts to Optimize Active Specific Immunotherapy for Melanoma (English)

1 reference

https://api.crossref.org/works/10.3109/08830189109114878

21 November 2022

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1779176

21 November 2022

1 reference

https://api.crossref.org/works/10.3109/08830189109114878

21 November 2022

author name string

M. S. Mitchell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1779176

21 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1779176

21 November 2022

publication date

1 January 1991

1 reference

full work available at URL

17 August 2017

http://www.tandfonline.com/doi/pdf/10.3109/08830189109114878

1 reference

https://api.crossref.org/works/10.3109/08830189109114878

International Reviews of Immunology

21 November 2022

published in

1 reference

17 August 2017

volume

7

1 reference

17 August 2017

issue

4

1 reference

17 August 2017

page(s)

331-347

1 reference

Active-specific immunotherapy for melanoma

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08830189109114878

Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189109114878

Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189109114878

Helper strategy in tumor immunology: expansion of helper lymphocytes and utilization of helper lymphokines for experimental and clinical immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189109114878

Lipid A and immunotherapy.

21 January 2018

2

1 reference

https://api.crossref.org/works/10.3109/08830189109114878

21 November 2022

3

48

5883

Mitchell M. S.

1988

1 reference

https://api.crossref.org/works/10.3109/08830189109114878

Quantitation of proliferative and cytotoxic precursor cells directed against human tumours: limiting dilution analysis in peripheral blood and at the tumour site

21 November 2022

7

1 reference

https://api.crossref.org/works/10.3109/08830189109114878

21 November 2022

9

44

5439

Berd D.

1984

1 reference

https://api.crossref.org/works/10.3109/08830189109114878

Cancer Immunology, Immunotherapy

21 November 2022

10

6

135

Vbsika G.

1979

1 reference

https://api.crossref.org/works/10.3109/08830189109114878

Active immunotherapy of human melanoma exploiting the immunopotentiating effects of cyclophosphamide

21 November 2022

15

1 reference

https://api.crossref.org/works/10.3109/08830189109114878

Development of class I-specific helper-inducer T-cell clone

21 November 2022

18

1 reference

https://api.crossref.org/works/10.3109/08830189109114878

Auto-tumor recognition following in vitro induction of MHC antigen expression on solid human tumors: stimulation of lymphocytes and generation of cytotoxicity against the original MHC-antigen-negative tumor cells

21 November 2022

19

1 reference

https://api.crossref.org/works/10.3109/08830189109114878

21 November 2022

20

51

1418

Hutchins J. T.

1991

1 reference

https://api.crossref.org/works/10.3109/08830189109114878

21 November 2022

Identifiers

1 reference

17 August 2017

1 reference